IL10 and neoplasm: In patients with HCC, anti-inflammatory compounds, including regulatory T (Treg) cells, tumor-associated macrophages (TAMs), myeloid-derived suppressor cells, and liver sinusoidal endothelial cells, express cytokines, such as interleukin- (IL-) 6, IL-10, and transforming growth factor- (TGF-) β [15, 16].